MAPK1 and neoplasm: Similar effects on tumor angiogenesis have been observed with luteolin, as it reduces phosphorylated VEGFR2 induced by VEGF-A and inhibits subsequent proteins including mTOR, AKT, P70S6K, ERK, MMP-2, and MMP-9 [30].